3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
20
Vitamin D Deficiency
17
Prostatic Neoplasms
14
Neoplasms
9
Polycystic Ovary Syndrome
8
Colonic Neoplasms
8
Rectal Neoplasms
6
Colorectal Neoplasms
6
Myelodysplastic Syndromes
5
Osteoporosis
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Cardiovascular Diseases
4
Warts
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Ovarian Neoplasms
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Brain Neoplasms
3
Adenomatous Polyps
3
Pathologic Processes
2
Pain
2
Obesity
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Musculoskeletal Diseases
2
Melanoma
2
Male Urogenital Diseases
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Interventions
World Health Organization oral rehydration solution
1
Vitamin D
1
Syringes
1
Nutrition Assessment
1
Injections, Intra-Articular
1
Fish Oils
1
Fatty Acids, Omega-3
1
Eicosapentaenoic Acid
1
Docosahexaenoic Acids
1
Cholecalciferol
1
Arthroplasty, Replacement, Shoulder
1
Arthroplasty, Replacement, Elbow
1
Adalimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Osteoarthritis
×
Cholecalciferol
×
Clear all
NCT01351805
2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA
Completed
25,871 enrolled
15 charts